CINGW Projected Dividend Yield
Wt Exp 12/03/2026/Cingulate Works Inc ( NASDAQ : CINGW )Cingulate is a holding company. Co. is engaged in clinical stage biopharmaceutical focused on the development of products using its key Precision Timed Release drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Co.'s two proprietary stimulant medications: CTx-1301 (dexmethylphenidate) and CTx-1302, are being developed for the treatment of ADHD intended for all patient segments: children (ages six to 12), adolescents (ages 13 to 17), and adults (ages18 plus). 20 YEAR PERFORMANCE RESULTS |
CINGW Dividend History Detail CINGW Dividend News CINGW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |